Introduction
============

The spread of antibiotic-resistant bacteria poses a great threat to public health and is growing worse since the current progress in developing of new antibiotics is limited ([@B11]). Aside from the introduction of carbapenems in 1985, all new antibiotics between the early 1960s and 2000 were synthetic derivatives of existing scaffolds, which often allow resistant strains to arise rapidly ([@B19]). Only in the USA the economic loss provoked by antibiotic resistance is estimated to be up to 55 billion USD per year with some data suggesting that the total cost can be even higher ([@B55]). Consequently, there is a need for new antimicrobials that can be used as alternatives to conventional antibiotics. Among such alternatives the antimicrobial peptides, the bacteriocins, are potential antibacterial agents to fight infections ([@B15]).

Bacteriocins are ribosomally synthesized peptides produced by bacteria to inhibit or kill other bacteria in competition for nutrients or habitats. They are almost with no exception cationic, amphiphilic, and heat-stable. The antimicrobial inhibition spectra and potency (strength) of bacteriocins differ greatly, with the majority being active only against closely related bacteria while some being much broader, targeting cells from different genera ([@B49]).

Bacteriocins have a number of advantages over conventional antibiotics and chemical food preservatives. Bacteriocins show antimicrobial activity at pico- to nanomolar concentrations and are commonly produced by bacteria found in many fermented foods and in the human gut microflora -- properties making them very attractive as natural food preservatives ([@B48]). Most bacteriocins from gram positive bacteria are known as membrane-active peptides, i.e., they disrupt membrane integrity, leading to leakage of intracellular solutes and cell death ([@B37]). This killing mechanism is different from that of most antibiotics, which often act as enzyme inhibitors of key metabolic pathways. Due to their different modes of action, bacteriocins do not discriminate between antibiotic resistant and sensitive bacteria ([@B15]).

Most bacteriocins are synthesized as a propeptide with an N-terminal leader which is removed by a dedicated ABC transporter or the Sec system during exporting from cells ([@B24]; [@B12]). However, there is a group of so-called leaderless bacteriocins, which are synthesized without an N-terminal leader and the mechanism behind their export is unknown. Leaderless bacteriocins are often relatively small (30--50 amino acids) and contain no modifications. These features make them relatively easy to obtain by synthetic means, thereby opening new opportunities for detailed bacteriocin study and design of new peptides with improved properties ([@B50]).

Enterocin K1 (EntK1) is a leaderless bacteriocin, which belongs to LsbB bacteriocin family. The family presently contains four members: LsbB, EntK1, EntQ, and EntEJ97 ([@B50]), all being leaderless and non-modified peptides. LsbB is a 30 amino acid (aa) residues peptide produced by *Lactococcus lactis.* It has a very narrow inhibition spectrum which contains only lactococcal strains ([@B21]). The remaining three bacteriocins are produced by different enterococcal strains. EntQ (34 aa residues) and especially EntEJ97 (44 aa residues) have broader antimicrobial spectra than LsbB ([@B22]; [@B13]; [@B6]). Less is known about the activity of the newly discovered EntK1 (37 aa residues), although it has been shown to inhibit *L. lactis* IL1403 ([@B50]).

It is has been shown for an increasing number of bacteriocins that they kill target cells in a receptor-mediated manner, i.e., bacteriocins recognize specific receptors on target cells where they bind and cause membrane-disruption that eventually leads to cell death ([@B17]; [@B14]). Recently, it has been shown that the lactococcal Zn-dependent metallopeptidase YvjB (also known as RseP) belonging to site-2 protease (S2P) protein family, serves as the receptor for LsbB ([@B57]; [@B46]). Our previous structure-function study of LsbB provided strong evidence that the peptide binds to its receptor using its unstructured C-terminal part ([@B50]).

In this work we determined the structure of EntK1, its activity spectrum and unravel the details behind target specificity of EntK1 and its sequence related bacteriocin EntEJ97. Based on the fact that RseP is involved in bacterial stress response ([@B59]) we developed an efficient strategy to improve the activity of EntK1 and its sequence related bacteriocins. We also showed that at least in *Enterococcus faecalis*, another membrane protein is responsible for bacterial sensitivity to EntEJ97, besides EntEJ97 receptor RseP.

Materials and Methods {#s1}
=====================

Bacterial Strains, Growth Conditions, Bacteriocins and Antimicrobial Assays
---------------------------------------------------------------------------

All the strains (see below) used in minimal inhibitory concentration (MIC) assays were grown in BHI medium (Oxoid) at 30°C without shaking. LsbB, EntK1, EntEJ97, and BHT-B bacteriocins were synthesized by Pepmic Co., Ltd, China with 98--99% purity. Synthesized peptides were solubilized to the concentrations of 10.0--0.1 mg/ml in 0.1% (vol/vol) trifluoroacetic acid and stored at -20°C until use. Bacteriocin garvicin ML was purified to 95% as described by ([@B9]). Bacteriocin activity was determined by microtiter plate assay as previously described ([@B29]). The MIC was defined as the minimal bacteriocin concentration that inhibited the growth of the indicator strain by at least 50% (50% of the turbidity of the control culture without bacteriocin) in 200 μl culture.

CD Spectroscopy
---------------

Circular dichroism (CD) spectra were recorded using a Jasco J-810 spectropolarimeter (Jasco International Co.) calibrated with [D]{.smallcaps}-camphor-10-sulfonate (Icatayama Chemical). All measurements were done using a quartz cuvette (Starna) with 0.1 cm path length at 25°C. Samples were scanned five times with a scanning rate of 50 nm/min with a bandwidth of 0.5 nm and response time of 1 s over the wavelength range 190--250 nm. Spectra were recorded at different (30 and 50%) trifluoroethanol (TFE) (Aldridge) concentrations at 25°C. The approximate α-helical content of the protein was estimated from its molar ellipticity at 222 nm ([@B53]).

NMR Spectroscopy
----------------

The experiments were run on a sample containing 1.0 mM EntK1, 50% D3-TFE (99.5% D) (Aldrich), Milli-Q water and 0.2 mM of 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) (Larodan).

2D NOESY ([@B32]), 2D TOCSY ([@B10]), 2D DQCOSY, ^15^N-HSQC ([@B16]), and^13^C-HSQC ([@B30]) were recorded. The data was acquired on a 600 MHz Bruker Avance II spectrometer with four channels and a 5 mm TCI cryoprobe (Bruker Biospin). NOESY spectra with mixing times between 120 and 300 ms were obtained for both samples. TOCSY mixing times of 15--80 ms was used. The experiments were run at 298.15 K. Spectra were processed using the Topspin program (Bruker Biospin). DSS was used as a chemical shift standard, and ^15^N and ^13^C data were referenced using frequency ratios as described in ([@B60]).

For visualization, assignment and integration of the spectra the computer program CARA was used ([@B35]). The spectra were assigned using standard methods ([@B61]).

Dihedral angle restraints were obtained from the chemical shift values using the program TALOS-N ([@B54]). Nuclear Overhauser effect (NOE) distance restraints were calculated from the peak volumes in the NOESY spectra with NOESY mixing time 200 ms.

All structure calculations were made using the structure calculation program CYANA 2.1 ([@B23]; [@B26]). The applied restraints are presented in **Table [1](#T1){ref-type="table"}**. The annealing macro in CYANA calculated 100 structures. The 20 structures with the lowest energy were kept and analyzed further. The root-mean-square deviation (RMSD) was calculated and the structures were visualized using MolMol ([@B39]).

###### 

Structure data and characteristics of the obtained NMR structures.

                                            EntK1 in 50% TFE
  ----------------------------------------- -------------------------
  Distance constraints                      561
       Intra residue                        162
       Sequential (ji - jj = 1)             176
       Medium range (1 \< ji - jj \< 5)     158
  Long range (ji - jj \> 5)                 24
  Dihedral angle constraints from TALOS-N   68
  Energies (Å^2^)§                          2.06 ± 0.01
  Violations^∗^                             0
  Deviations from idealized geometry        
       Bonds (Å)                            7.4 ± 0 × 10^-3^
       Angles (°)                           1.1 ± 0.01
  Ramachandran plot                         
       % in favored regions                 77.7
  \% in allowed regions                     22.3
  Mean pairwise RMSD                        
  Backbone/Heavy atoms                      0.49 ± 0.19/1.11 ± 0.24
  Backbone (8--24)/Heavy atoms (8--24)      0.01 ± 0.00/0.52 ± 0.15

§CYANA energy.

∗

Only violations larger than 0.2 Å or 5°

.

Generation of Bacteriocin Resistant Mutants of *E. faecalis* and *E. faecium*
-----------------------------------------------------------------------------

EntEJ97 and EntK1-resistant mutants were obtained by spot-on-lawn assay using 20 μl of bacteriocin with concentration 1.0--0.1 mg/ml. After overnight incubation at 30°C, resistant colonies of *E. faecalis* LMG3358 (resistant to EntEJ97) and *E. faecium* LMG2787 (resistant to EntEJ97 and EntK1) appeared within the inhibition zones. Resistant isolates were picked and re-streaked on plates for pure cultures before frozen cultures containing 15% glycerol were made and stored at -80°C. The level of resistance against EntEJ97 and EntK1 was determined by a microtitre plate assay ([@B29]). DNA from the bacteriocin resistant mutants was extracted from overnight cultures with a GenElute^TM^ Bacterial Genomic DNA Kit (Sigma--Aldrich) and PCR of the *rseP* gene was performed using primers Ent, EF (F, M, R) (**Table [2](#T2){ref-type="table"}**). For sequencing of *E. faecium* LMG2787 mutants with transposons inside *rseP*, additional primers (EF_R2, T1_F, T2_F, and T3_F) were created (**Table [2](#T2){ref-type="table"}**). PCR products were purified with NucleoSpin Extract II (Macherey-Nagel, Düren, Germany) and sent to GATC Biotech, Germany, for sequencing.

###### 

Primers used in the study.

  Primer     Oligonucleotide sequence (5′?3′)                     Reference
  ---------- ---------------------------------------------------- ------------
  Ent_F      CGAAGTGGTCAAGTCCAATGGT                               This study
  Ent_M      GTGCGGATTGCGCCACTTGAC                                This study
  Ent_R      GATGACTTAAGACTTCTGCATCAT                             This study
  EF_F       GCTCTTAGCAAGATTTGATGGC                               This study
  EF_M       CGTCCACACTGACTACCTCATC                               This study
  EF_R       CTTAGACCGTTTCGACAGTTTGC                              This study
  EF_R2      TGCAATCTGTCGACGTGACAC                                This study
  T1_F       AGCTAGCTCAAAGGAAGAGGC                                This study
  T2_F       TGCAATCTGTCGACGTGACAC                                This study
  T3_F       GCTCGAACAGCTAAGAATGCCT                               This study
  th009      ACGTTTGAGCAATTTCCTTCC                                This study
  th010      CACATTATCCATTAAAAATCAAACAGCGTTTCCTCCGTCTTTTG         This study
  th011      GTCCAAAAGCATAAGGAAAGTCGAGGAATATTATGAAACAAAG          This study
  th012      CATTTCCAACTAGAAGGGCTG                                This study
  ds171      ATTTATATTTATTATTGGAGGTTCAATGAAAACAATTATCACATTCA      This study
  ds172      ATTGGGAAGAGTTACATATTAGAAATTAAAAGAAAAAGCGTTGAATATC    This study
  ds87       AGCGTTTCCTCCGTCTTTTG                                 This study
  ds88       CAAAAGACGGAGGAAACGCTTCGAGGAATATTATGAAACAAAG          This study
  Kan484.F   GTTTGATTTTTAATGGATAATGTG                             [@B34]
  RpsL41.R   CTTTCCTTATGCTTTTGGAC                                 [@B34]
  khb31      ATAACAAATCCAGTAGCTTTGG                               [@B7]
  khb33      TTTCTAATATGTAACTCTTCCCAAT                            [@B7]
  khb34      CATCGGAACCTATACTCTTTTAG                              [@B7]
  khb36      TGAACCTCCAATAATAAATATAAAT                            [@B7]
  466p1      GGTATTCTTGTCCTCGTAGCTGAATTTGGCCACTTTTATTTTGC         This study
  467p2      GCAAAATAAAAGTGGCCAAATTCAGCTACGAGGACAAGAATACC         This study
  468p1      ATTCTTGTCCTCGTACATGCATTTGGCCACTTTTATTTTGCAAAAC       This study
  469p2      GTTTTGCAAAATAAAAGTGGCCAAATGCATGTACGAGGACAAGAAT       This study
  470p1      GTACATGAATTTGGCGCTTTTTATTTTGCAAAACGAGC               This study
  471p2      GCTCGTTTTGCAAAATAAAAAGCGCCAAATTCATGTAC               This study
  472-p1     GAATTTGGCCACTTTGCTTTTGCAAAACGAGC                     This study
  473-p2     GCTCGTTTTGCAAAAGCAAAGTGGCCAAATTC                     This study
  474p1      ATTCTTGTCCTCGTAGCTGCATTTGGCGCCTTTTATTTTGCAAAACGAGC   This study
  475p2      GCTCGTTTTGCAAAATAAAAGGCGCCAAATGCAGCTACGAGGACAAGAAT   This study

Construction of *S. pneumoniae* Transformants and Mutants of *rseP*
-------------------------------------------------------------------

To express the *E. faecalis rseP* gene heterologously in *S. pneumoniae*, the gene was placed by homologous recombination in the genome of strain SPH131, behind the ComS-inducible P*~comX~* promoter (ComRS system) ([@B7]). The P*~comX~*-*rseP* construct was created by overlap extension PCR ([@B27]). First, the *E. faecalis* LMG3358 *rseP* was amplified using the primer pair ds171/ds172 with genomic *E. faecalis* DNA as template. The P*~comX~* promoter and its ∼1000 bp upstream and downstream regions were amplified using the primer pairs khb31/khb36 and khb33/khb34, respectively. Genomic DNA derived from strain SPH131 served as template. The P*~comX~* with its upstream region was fused to the 5′ end of the *E. faecalis rseP* gene using the primers khb31 and ds172. The P*~comX~* downstream fragment was fused to the 3′ end of the *rseP* gene using primer pair ds171 and khb34. Finally, these two fragments were fused using primer khb31 and khb34 giving rise to P*~comX~*-*rseP*. The Janus cassette ([@B56]) in strain SPH131 was replaced with the P*~comX~*-*rseP* fragment by natural transformation, giving rise to strain ds218 (**Table [3](#T3){ref-type="table"}** and Supplementary Figure [1](#SM1){ref-type="supplementary-material"}).

###### 

*Streptococcus pneumoniae* strains used in the study.

  Strain   Genotype/relevant features^a^                                                                          Reference/source
  -------- ------------------------------------------------------------------------------------------------------ ------------------
  RH1      *S. pneumoniae*, R704, but *ebg*::*spc*; Ery^r^ Spc^r^                                                 [@B34]
  RH426    *S. pneumoniae*, contains the Janus cassette; Ery^r^ Kan^r^                                            [@B33]
  SPH131   *S. pneumoniae*, contains the ComRS system, Janus cassette is placed behind P*~comX~*; Ery^r^ Kan^r^   [@B7]
  ds218    *S. pneumoniae* SPH131 but Δjanus:: *rseP* from *E. faecalis* LMG5833                                  This study
  ds219    *S. pneumoniae* ds218 but Δ*rseP*~wt~::janus                                                           This study
  ds220    *S. pneumoniae* ds219 but Δjanus                                                                       This study
  ds221    *S. pneumoniae* ds220 but Δ *rseP*::janus                                                              This study
  ms1      *S. pneumoniae* ds221 but Δjanus::*EF-rseP-H18 \> A*                                                   This study
  ms2      *S. pneumoniae* ds221 but Δjanus::*EF-rseP-E19 \> A*                                                   This study
  ms3      *S. pneumoniae* ds221 but Δjanus::*EF-rseP-H22 \> A*                                                   This study
  ms4      *S. pneumoniae* ds221 but Δjanus::*EF-rseP-Y24 \> A*                                                   This study
  ms5      *S. pneumoniae* ds221 but Δjanus::*EF-rseP-HExxH \> AAxxA*                                             This study

a

Cm, chloramphenicol; Ery, erythromycin; Spc, spectinomycin; Kan, kanamycin; Sm, streptomycin

.

*Streptococcus pneumoniae* has a gene homologous to the lactococcal *rseP*. To avoid the potential background noise of the *S. pneumoniae rseP*, this gene was removed from the genome in strain ds218 using the Janus cassette ([@B56]). An *rseP* deletion cassette was constructed by amplifying Janus with the primers kan484F and RpsL41.R ([@B34]) where genomic DNA from strain RH426 ([@B34]) served as template. The Janus cassette was then fused to the ∼1000 bp upstream \[primers th009 and th010 with genomic RH1 ([@B34]) DNA as template\] and downstream region (primers th011 and th012 with genomic RH1 DNA as template) of *rseP* using primers th009 and th012. The resulting fragment was used to transform strain ds218 resulting in the replacement of *S. pneumoniae rseP* with Janus generating strain ds219. Janus was then removed from strain ds219 by transforming with a fragment consisting of the *rseP* flanking regions only. This fragment was constructed by amplifying the *rseP* ∼1000 bp upstream region using primers th009 and ds87, while the ∼1000 bp downstream region was amplified with the primers ds88 and th012. The upstream and downstream fragments where then fused using the primers pair th009/th012. The resulting fragment was used to replace the Janus in strain ds219 resulting in strain ds220 (**Table [3](#T3){ref-type="table"}** and Supplementary Figure [1](#SM1){ref-type="supplementary-material"}).

To create a strain expressing point mutated *rseP* genes we replaced the *E. faecalis* 3358 *rseP* in strain ds220 with Janus cassette giving rise to strain ds221. This Janus cassette was amplified with the primer pair khb31/khb34 and genomic DNA from strain SPH131 served as template. Selected residues in RseP were substituted with alanines by a PCR approach, using primer pairs listed in **Table [2](#T2){ref-type="table"}**. The resulting DNA pair fragments were subsequently fused using the primers khb31 and khb34. The resulting fragment was used to replace Janus cassette in strain ds221 giving rise to strains ms1-5 (**Table [3](#T3){ref-type="table"}**). Ectopic expression of the *rseP* gene in strain ds220 and ms1-5 was induced with the synthetic ComS peptide (NH2-LPYFAGCL-COOH) (Genosphere Biotechnologies) as described by [@B7].

Results
=======

Structural Analysis of EntK1 by CD and NMR-Spectroscopy
-------------------------------------------------------

Circular dichroism spectra of EntK1 showed that it was unstructured in water but became structured in TFE solution (Supplementary Figure [2](#SM2){ref-type="supplementary-material"}). Maximum structuring was obtained in 50% TFE (55% α-helical content). This concentration was consequently used in the NMR experiment.

The NMR spectra were assigned using standard methods as described in "Materials and Methods." Supplementary Figure [3](#SM3){ref-type="supplementary-material"} shows the assigned ^15^N HSQC spectrum of EntK1 in 50% TFE. **Figure [1](#F1){ref-type="fig"}** shows connected strips from NOESY, the torsion angle restraints used in structure calculations and the Hα chemical shift indexes (CSIs). CSI (low Hα ppm values) ([@B45]) indicates that there is an α-helix in EntK1 from residue 8 to 27 and TALOS-N torsion angle predictions ([@B54]) indicated backbone torsion angles (ϕ- and ψ-angle) consistent with α-helical regions from residue 8 to 25 (**Figure [1](#F1){ref-type="fig"}**).

![**Results from analysis of NMR chemical shifts and nuclear Overhauser effects (NOE's) of EntK1 in TFE**. Chemical shift index (CSI) of Hα carbons is shown in **(A)**. Intermediate NOE restraints and residues where determined torsion angles from the chemical shifts are shown in **(B)**. The signs ^∗^ and ˆ indicate that TALOS determined phi and psi torsion angle restraints, the ^∗^ are used to symbolize torsion angle restraints in the α-helical region of the Ramachandran plot while ˆ is used for all other torsion angles. The lines indicate typical α-helical restraints obtained from analysis of the NOE spectra. Thicknesses of the lines shown are related to NOE cross peak intensities.](fmicb-08-00774-g001){#F1}

A total of 561 (15.1 per residue) unique NOE connectivities were assigned. The total number of distance restrictions and their classes are shown in **Table [1](#T1){ref-type="table"}**. The mid-range NOE connectivities that are especially important for α-helices, NN(i, i+2), αN(i, i+2), αN(i, i+3), αβ(i, i+3), and αN(i, i+4), are shown in **Figure [1](#F1){ref-type="fig"}**. In the presence of TFE, the observed connectivities indicated an α-helical region stretching from residue 8 to 26.

Structures of EntK1 based on the experimentally obtained constrains were calculated using CYANA. A superimposition of the structure ensemble of the 20 lowest energy structures of EntK1 and the cartoon depiction of the lowest energy structure of EntK1 are shown in **Figures [2A,B](#F2){ref-type="fig"}**, respectively. The NMR structure of EntK1 contains an α-helix from residue 8 to 24. The structure ensemble has been deposited to the Protein Data Bank with access code: 5L82 and the NMR data have been deposited to the Biomagnetic Resonance Data Bank with the access code 34006.

![**NMR structure of EntK1 **(A,B)** compared with LsbB **(C,D)** ([@B50]) in 50% TFE**. The structures ensembles of the 20 lowest energy structures superimposed are shown in **(A,C)** and cartoon representations of the lowest energy structures are shown in **(B,D)**.](fmicb-08-00774-g002){#F2}

The Inhibitory Spectra of the EntK1 and Two Sequence Related Bacteriocins
-------------------------------------------------------------------------

A sizable collection of Gram-positive bacteria from different species and genera was used as indicators to assess the inhibition spectra of the bacteriocins EntK1, EntEJ97, and LsbB (**Table [4](#T4){ref-type="table"}**). EntQ, which is a member of the LsbB family bacteriocins, was not tested because synthetic EntQ peptides had poor activity, likely due to formation of disulphide bridges between and inside the molecules, since adding reducing agents (e.g., DTT) restored some of the activity of EntQ (data not shown). As seen in **Table [4](#T4){ref-type="table"}**, the antimicrobial spectra of EntK1, EntEJ97, and LsbB differ greatly. LsbB was active only against *L. lactis* IL1403, one of the four strains of *L. lactis* tested and it had no activity against other genera and species. EntK1 was active mostly against *E. faecium* and *E. hirae* and some lactococcal strains. EntEJ97 showed the broadest activity spectrum, inhibiting *E. faecium, E. faecalis, L. lactis, Staphylococcus aureus, Lactococcus garvieae*, and *Listeria monocytogenes*. It is noteworthy that EntK1 appeared to have significantly lower MIC values (i.e., being more potent) than EntEJ97 against *E. faecium*, but was inactive against *E. faecalis* (**Table [4](#T4){ref-type="table"}**). Similarly, all three bacteriocins were active against the *L. lactis* IL1403, but LsbB was about 340 and 70 times more potent than EntK1 and EntEJ97, respectively (**Table [4](#T4){ref-type="table"}**).

###### 

Minimal inhibitory concentration (MIC) values (nM) of EntK1 and its related bacteriocins against different bacterial species.

  Indicator strain^∗^                      LsbB     EntK1           Ent-EJ97
  ---------------------------------------- -------- --------------- --------------
  *Staphylococcus aureus* (*n* = 6)        \>7000   \>5500          590- \>4500
  *Staphylococcus epidermidis* (*n* = 1)   \>7000   \>5500          \>4700
  *Enterococcus faecalis* (*n* = 11)       \>7000   2700- \> 5500   145--295
  *Enterococcus faecium* (*n* = 8)         \>7000   10--85          145--295
  *Enterococcus faecium* (*n* = 10)^∗∗^    \>7000   10--45          75--145
  *Enterococcus hirae* (*n* = 1)           \>7000   45              75
  *Lactococcus garvieae* (*n* = 2)         \>7000   340--1370       295
  *Lactobacillus* spp. (*n* = 3)           \>7000   5500- \>5500    145- \>4700
  *Lactococcus lactis* IL1403              0.5      170             37
  *Lactococcus lactis* (*n* = 3)           \>7000   \>5500          145--295
  *Bacillus cereus* (*n* = 5)              \>7000   2750- \>5500    2300- \>4700
  *Listeria monocytogenes* (*n* = 2)       \>7000   \>5500          1175--2300

∗

The numbers in parentheses are referred to the number of strains tested.

∗∗

Nosocomial isolates from different European hospitals, including VRE

.

Different Levels of Resistance against EntK1 and EntEJ97 in *E. faecalis* and *E. faecium*
------------------------------------------------------------------------------------------

The strain *E. faecium* LMG2787 was used to generate mutants resistant to EntK1 and EntEJ97. Since *E. faecalis* is resistant to EntK1, *E. faecalis* LMG3358 was used to generate mutants resistant only to EntEJ97. The two enterococcal strains were exposed to various concentrations of EntEJ97 and EntK1 at 30°C and relatively many resistant colonies appeared within the inhibition zones on agar plates (see below). For *E. faecalis*, 12 EntEJ97 resistant colonies were randomly selected and examined for resistance to EntEJ97 by microtiter assays. Similarly, six EntEJ97 and six EntK1mutants of *E. faecium* were selected for further analysis.

Two levels of *E. faecalis* resistance to EntEJ97 were found: seven colonies were highly resistant (HR) -- at least 500 times more compared to the wild type (WT) strain. The second set of five colonies showed a lower resistance (LR) level, being about 16--32 times more resistant than the WT *E. faecalis*. For *E. faecium* only HR (at least 500 times against EntK1 and EntEJ97, compared to WT) type mutants were found. When all these mutants were challenged with the non-related bacteriocins BHT-B ([@B31]) and garvicin ML ([@B9]), they were found as sensitive as the WT strains (data not shown). These results clearly imply the involvement of specific resistance mechanism(s) toward EntEJ97/EntK1 amongst these mutants.

Highly Resistant Mutants of *E. faecalis* and *E. faecium* Have Mutations in the *rseP* Gene
--------------------------------------------------------------------------------------------

As the lactococcal RseP has previously been found to serve as receptor for LsbB, we suspected that the RseP homologous in *Enterococcus* might serve the same function for the LsbB sequence related EntEJ97/EntK1 bacteriocins. The DNA regions containing *rseP* in all the EntEJ97/EntK1-resistant mutants (high and low) were therefore obtained by PCR and sequenced. Different types of mutations were found. For *E. faecalis*, all seven HR mutants contained either one or three consecutive 8-bp repeats of the sequence CAAAAAAT within the *rseP* gene, while the WT *rseP* has two such repeats. On the other hand, all *E. faecium* HR mutants carried a transposon within *rseP* (**Figure [3](#F3){ref-type="fig"}**). In all cases, these mutations caused frameshift in *rseP* and premature termination, indicating that a functional ResP is necessary for the sensitivity toward EntEJ97/EntK1. Surprisingly, no mutations were found in *rseP* from all five EntEJ97 LR mutants of *E. faecalis*, indicating that additional genes can affect the sensitivity of the bacterium to these bacteriocins. This latter aspect will be further mentioned in the "Discussion" section.

![**Transposon insertions in *E. faecium* LMG2787 *rseP* mutants (B30--B80) compared to the wild type (WT)**.](fmicb-08-00774-g003){#F3}

*rseP* Expression in *S. pneumoniae* Confers Sensitivity to EntEJ97/EntK1
-------------------------------------------------------------------------

In order to confirm that the expression of *rseP* is sufficient to confer sensitivity to EntEJ97 and EntK1, the *rseP* gene from *E. faecalis* LMG3358 was heterologously expressed in the distantly related and non-sensitive host *S. pneumoniae* strain SPH131 as described in ([@B7]). To avoid potential background noise the endogenous *rseP* of *S. pneumoniae* SPH131 was removed by homologous recombination, giving rise to the clone *S. pneumoniae* ds220 with the endogenous *rseP* deleted but with the enterococcal *rseP* expressed under the control of the inducible promoter P*~comX~* ([@B7]). While non-induced cells were not sensitive to EntEJ97 and EntK1, they became sensitive to the bacteriocins upon induction of *rseP* (**Table [5](#T5){ref-type="table"}**). The results indicate that the enterococcal *rseP* is indeed directly involved in the sensitivity to EntEJ97 and EntK1. Further, it should be noted that the induced clone (expressing the *E. faecalis rseP*) was most sensitive to EntEJ97 (MIC of 18 nM), intermediate-sensitive to EntK1 (MIC of 700 nM), and poorly sensitive to LsbB (MIC \> 7000 nM). This observation is line with the results presented in **Table [4](#T4){ref-type="table"}**, where the *E. faecalis* strains showed a corresponding differentiation in sensitivity to the three bacteriocins.

###### 

Sensitivity of *S. pneumonia* clones to EntEJ97, EntK1, and LsbB.

  Strain                Mutation         MIC (nM)^∗^            
  --------------------- ---------------- ------------- -------- --------
  ' ds220 non-induced   WT *rseP*        \>4500        \>5500   \>7000
  ds220 induced         WT *rseP*        18            700      \>7000
  ms1                   H18 \> A         300           \>5500   \>7000
  ms2                   E19 \> A         300           \>5500   \>7000
  ms3                   H22 \> A         300           \>5500   \>7000
  ms4                   Y24 \> A         18            700      \>7000
  ms5                   HExxH \> AAxxA   600           \>5500   \>7000
  ds 221                no *rseP*        \>4500        \>5500   \>7000

∗

Bacteriocins were active only when

rseP

was induced with ComS (2 μM). Without ComS the cells were resistant to the bacteriocins. ComS was not toxic to the cells even at 20 μM

.

Mutations within the Active Site of RseP Reduce Sensitivity to EntEJ97/EntK1
----------------------------------------------------------------------------

Members of the RseP protein family have a conserved proteolytic motif (HExxH, where x is any amino acid) located within the first transmembrane helix ([@B38]). To analyze whether this active site is important for bacteriocin sensitivity, we changed the invariant residues in this motif (i.e., H18, E19, and H22), one by one, and three altogether in the enterococcal RseP to alanine and then assessed for bacteriocin sensitivity. In addition, the non-conserved residue Y24 located nearby the active site was replaced with alanine to serve as a control. The result showed that all clones expressing the RseP protein in which conserved residues were changed to alanine became less sensitive to EntEJ97 and EntK1, especially when all three conserved residues were replaced with alanine (30 times less sensitive to EntEJ97 than the WT) (**Table [5](#T5){ref-type="table"}**). In the control clone (Y24 \> A) no changes in the bacteriocin sensitivity were observed. This result demonstrates that the active site of RseP is essential for bacteriocin activity.

The Growth of EntK1/EntEJ97 Resistant Mutants Is Prevented at Elevated Growth Temperature
-----------------------------------------------------------------------------------------

RseP protein is known to play a key role in bacterial stress response in *Escherichia coli*, *Bacillus subtilis*, and other bacteria ([@B4]; [@B59]; [@B36]). We therefore examined how elevated growth temperature as a stress factor, influences the development of EntEJ97 and EntK1 resistance in *E. faecium* and *E. faecalis*. As expected resistant mutants only appeared at 30°C but not at 45°C (**Figure [4](#F4){ref-type="fig"}**). Cell counts of WT cultures grown for 8 h at 30 and 45°C in BHI broth showed that the cell number at 30°C was only about 1.2 times higher than that at 45°C (data not shown), implying that the lack of resistant mutants at the elevated temperature was not due to poor growth of WT cells but rather due to lack of development of resistant mutants. This is further supported by the fact that EntEJ97/EntK1-resistant mutants with a non-functional *rseP* gene (described above) obtained at 30°C could not grow at 45°C, while WT cells grew well (data not shown).

![**EntK1 and EntEJ97 resistant mutants appear on at 30°C but not at the elevated temperature 45°C**. Bacteriocin (20 μl of 1 mg/ml) was applied to soft agar containing indicator cells on plates, which was then incubated overnight at indicated temperatures for growth and developing the inhibition zones and resistant colonies.](fmicb-08-00774-g004){#F4}

Discussion
==========

Structural analyses by CD spectroscopy showed that EntK1 was unstructured in water but became structured when exposed to membrane-mimicking environments (DPC-micelles or TFE). This is a common property for the majority of bacteriocins ([@B47]; [@B44]).

The structure of EntK1 in 50% TFE is very similar to that of LsbB (**Figure [2](#F2){ref-type="fig"}**). Both bacteriocins have an N-terminal part mostly composed of an amphiphilic α-helical motif, and an unstructured C-terminal half. EntK1 α-helix is longer than the one of LsbB, being 16--19 residues, versus 13--15 residues in LsbB. A closer look at the α-helices of EntK1 and LsbB showed that both are amphiphilic with the basic amino acids along one side of the helix and non-polar residues along the other side (data not shown). Such amphiphilic distribution is common for many bacteriocins as well as other antimicrobial peptides ([@B40]; [@B52]; [@B42]). The α-helical part of the bacteriocins is probably involved in pore-formation, where the hydrophobic part is facing the hydrophobic membrane or a membrane-located protein (receptor) while the hydrophilic part is facing the inner part of the pore to cause cellular leakage ([@B37]).

The C-terminal unstructured parts of EntK1 and LsbB are about the same lengths, 10--13 residues and more similar in sequence. Structure prediction servers (PONDR^®^VL-XT, JPred 4) indicated that EntEJ97 also contains an α-helix from Lys10 to Gly 35 with an unstructured C-terminal tail of 10 residues, which corresponds with our data on LsbB and EntK1 structures.

Besides EntK1 and LsbB, structures of three other leaderless bacteriocins have been obtained so far (enterocin 7, lacticin Q, and aureocin A53). Enterocin 7 is a two-peptide bacteriocin, where the two peptides constituting the bacteriocin are related in sequence and both have a similar fold, consisting of N-terminal, middle and C-terminal helices ([@B43]). Lacticin Q and aureocin A53 both consist of four helices surrounding a hydrophobic core ([@B1]). The structures of enterocin 7, lacticin Q, and aureocin A53 resemble the structure of circular bacteriocins, and all of them are highly structured in aqueous solutions. As such, EntK1 and LsbB are very different from these bacteriocins by being smaller (30 and 37 residues for LsbB and K1 versus 43--53 residues for the others), unstructured in water (partly due to the absence of any modifications such as disulphide bridges or circularization in these leaderless bacteriocins) and containing only one helix (**Figure [2](#F2){ref-type="fig"}**).

The lactococcal Zn-dependent metallopeptidase RseP has been shown to be the receptor for LsbB in *L. lactis* IL1403 ([@B57]; [@B46]). Our present study provides strong evidence that EntEJ97 and EntK1 employ the homologous RseP in enterococci as receptor. This is based on the fact that mutants of *E. faecalis* LMG3358 and *E. faecium* LMG2787 that are HR to EntEJ97/EntK1, contain frameshift mutations in *rseP* and, more conclusively, heterologous expression of the enterococcal *rseP* rendered resistant pneumococcal cells sensitive to these bacteriocins (**Table [5](#T5){ref-type="table"}**). However, at least in the case of *E. faecalis* LMG3358, we also found some EntEJ97-resistant mutants, which were less resistant, compared to those with mutated *rseP* and had intact *rseP*, suggesting that these probably had mutations in other gene(s), see discussion below. Nevertheless, both types of resistance were specific to EntEJ97 and EntK1 because all resistant cells were sensitive to the non-related bacteriocins BHT-B (leaderless type) and garvicin ML (circular type). Furthermore, both (high and low) types of resistance share one common feature, that they emerged at the standard growth temperature 30°C but not at the elevated 45°C, indicating that both resistance types are linked to stress response (**Figure [4](#F4){ref-type="fig"}**). Indeed, RseP has been shown to be involved in stress response in some bacteria. In *Escherichia coli*, cell envelope stress response leads to proteolytic cleavage of the membrane-bound anti-sigma protein RseA by the RseP protease that eventually leads to σE release in the cytoplasm to transcribe stress response genes ([@B41]; [@B28]; [@B3]). Similarly, in *E. faecalis*, RseP (also known as Eep) is involved in the stress response via degradation of the anti-sigma protein RsiV. This degradation leads to activation of SigV -- enterococcal extracytoplasmic sigma protein that plays a key role in stress response ([@B59]). Furthermore, RseP deletion mutants have shown increased susceptibility toward heat, ethanol, lysozyme, and acid compared to the susceptibility of the WT strain ([@B59]).

Interestingly, RseP of *E. faecalis* is also involved in a proteolysis of the sex pheromone precursor peptide to form an active pheromone (cCF10) which is released by a cognate ABC transporter, called PptAB. It belongs to the EcsAB family and is composed of two proteins -- PptA and PptB ([@B58]). It has also been shown in *Bacillus subtilis* that mutations within EcsAB blocked the activity of RasP (*Bacillus* homolog of enterococcal RseP) and made the cells sensitive to stress ([@B25]). Remarkably, when we did whole genome sequencing of the five *E. faecalis* LR mutants with intact *rseP* gene, we discovered frequent mutations within genes *pptA* and *pptB* (preliminary results). Moreover, in EntEJ97 LR mutants of *Pediococcus acidilactici* and *Lactococcus garvieae*, all with an intact *rseP* gene also had mutations in *ecsA* and *ecsB* (data not shown).

Thus, our results also revealed a functional connection between these two systems: RseP and EcsAB, that both are involved in the sensitivity to our bacteriocins. As mentioned elsewhere, YvjB (a homolog of RseP) serves as receptor for LsbB which binds directly to the receptor upon killing target cells ([@B46]). At present it is not clear the exact role of EcsAB in the sensitivity to bacteriocins. Whether it is directly involved as a receptor as described for RseP or in regulation of RseP function or gene expression awaits further investigation.

Members of the RseP protein family are membrane-bound proteins, most if not all, containing multiple transmembrane helices. The putative active site of RseP proteases is normally located within the hydrophobic plane of the membrane and contains a consensus sequence motif HExxH, in which the two histidine residues are thought to coordinate a zinc atom together with a conserved glutamate residue ([@B18]; [@B38]; [@B51]). Our results indicate that the active site of RseP is somehow involved in the sensitivity to the bacteriocins. This is based on the observation that replacing of the conserved residues with alanine residues in *E. faecalis* RseP made the cloned cells less sensitive to EntEJ97 and EntK1 especially when all three conserved residues were replaced. This finding is different from other known bacteriocin receptor systems. Substitution mutations of conserved active site residues in LsrS -- Zn-dependent membrane protein, serving as receptor for the two-peptide lantibiotic bacteriocin Smb, had no effect on cells sensitivity to the bacteriocin ([@B8]). Similarly, the man-PTS membrane-located components IIC and IID can serve as a receptor for pediocin-like bacteriocins even without its cytosolic component (IIAB) which is needed for functional sugar transport ([@B17]). How the active site of RseP involved in the sensitivity to EntK1/EntEJ95 is still elusive. The structure of RseP homologous protein from archaebacterial species *Methanocaldococcus jannaschii* showed that it is quite dynamic during the proteolytic reaction. The protein displays structural changes including the movement of the transmembrane helices to bring the substrate (a peptide or part of a protein) into the active site and to release the digested product after proteolysis ([@B18]). It is tempting to speculate that site-directed mutations in the active site of RseP might have altered its 3D-structure, making it less accessible for the bacteriocins. Other possibilities might also exist. For example, these mutations could somehow create a less stable or incorrectly folded RseP protein that was removed from cells by chaperone proteases.

The study of EntK1 and EntEJ97 inhibition spectrum showed an interesting detail -- EntK1 was less active and had generally narrower antibacterial spectrum than EntEJ97. However, against *E. faecium* strains EntK1 was much more potent (i.e., lower MIC values) than EntEJ97. The latter was equally active against *E. faecalis* and *E. faecium* (**Table [4](#T4){ref-type="table"}**). Since EntK1 is produced by *E. faecium* and EntEJ97 by *E. faecalis*, this difference is in line with the general characteristic of bacteriocins, namely that they are most active against species closely related to the producers. This narrow-spectrum activity is not well understood in terms of mechanisms, but likely has an ecological meaning, e.g, giving the bacteriocin producer an advantage in competition for nutrients or habitats over its closest competitors. However, multiple sequence alignment analysis (using Clustal Omega) of many RseP (30 from *E. faecalis* and 30 from *E. faecium*) did not show any pronounced differences between the two RseP groups (data not shown). Thus, what properties of RseP that define the different levels of sensitivity toward EntEJ97 and EntK1 awaits further investigation.

During the past few decades, enterococci have emerged as important healthcare-associated pathogens due to their resistance to antibiotics and environmental stress factors ([@B5]). The rapid spread of *E. faecium* with resistance to vancomycin (VRE), ampicillin and high-levels of aminoglycosides is of particular concern ([@B2]). *E. faecium* is now a nosocomial pathogen as common as *E. faecalis* ([@B5]). Recently RseP was shown to be a major virulence determinant in enterococcal rabbit endocarditis model ([@B20]). The importance of RseP in virulence is most likely due to its role in stress response ([@B59]). Therefore, EntK1 and EntEJ97, both targeting enterococcal RseP, can be used in combination with stress factors to effectively kill antibiotic-resistant enterococci including VRE.
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